Voyager Therapeutics (VYGR) Profit After Tax (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.86% |
| Dec 31, 2025 | 1.67% |
| Sep 30, 2025 | 16.45% |
| Jun 30, 2025 | -7.61% |
| Mar 31, 2025 | 10.05% |
| Dec 31, 2024 | -281.32% |
| Sep 30, 2024 | 10.82% |
| Jun 30, 2024 | 10.49% |
| Mar 31, 2024 | -120.09% |
| Dec 31, 2023 | 317.73% |
| Sep 30, 2023 | -16.63% |
| Jun 30, 2023 | -117.90% |
| Mar 31, 2023 | 625.03% |
| Dec 31, 2022 | -234.06% |
| Sep 30, 2022 | 192.34% |
| Jun 30, 2022 | 10.47% |
| Mar 31, 2022 | -473.43% |
| Dec 31, 2021 | 122.71% |
| Sep 30, 2021 | 16.54% |
| Jun 30, 2021 | -39.13% |
| Mar 31, 2021 | -35.93% |
| Dec 31, 2020 | -118.60% |
| Sep 30, 2020 | 1,086.19% |
| Jun 30, 2020 | 64.22% |
| Mar 31, 2020 | -92.96% |
| Dec 31, 2019 | 16.21% |
| Sep 30, 2019 | -234.55% |
| Jun 30, 2019 | 141.05% |
| Mar 31, 2019 | -20.58% |
| Dec 31, 2018 | -11.06% |
| Sep 30, 2018 | 20.56% |
| Jun 30, 2018 | -28.18% |
| Mar 31, 2018 | -68.46% |
| Dec 31, 2017 | 49.34% |
| Sep 30, 2017 | -23.68% |
| Jun 30, 2017 | -13.38% |
| Mar 31, 2017 | -13.46% |
| Dec 31, 2016 | -63.11% |
| Sep 30, 2016 | 3.63% |
| Jun 30, 2016 | -29.87% |
| Mar 31, 2016 | 1.30% |
| Dec 31, 2015 | -85.93% |
| Sep 30, 2015 | -0.56% |
| Jun 30, 2015 | 73.28% |
| Mar 31, 2015 | -210.81% |
| Dec 31, 2014 | -17.10% |